Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 1918-1924

  Doi, Hideki ^a   Kugiyama, Kiyotaka ^a   Ohgushi, Masamichi ^a   Sugiyama, Seigo ^a   Matsumura, Toshiyuki ^a   Ohta, Yasutaka ^a   Oka, Hideki ^a   Ogata, Nobuhiko ^a   Hirata, Akira ^a   Yamamoto, Yorihiro ^b   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Antioxidants; Endothelial derived factors; Endothelium; Hyperlipoproteinemia; Lipoproteins

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; GLUTATHIONE; HYDROPEROXIDE; LIPOPROTEIN; PHOSPHATIDYLCHOLINE;

ANIMAL TISSUE; AORTA; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ECHINOCYTE; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; VASODILATATION;

EID: 0032790919     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.1918     Document Type: Article

References (32)

1. Doi H, Kugiyama K, Ohgushi M, Sugiyama S, Matsumura T, Ohta Y, Nakano T, Nakajima K, Yasue H. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 1998;137:341-349.
2. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, Nakagawa O, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Nakano T, Nakajima Y, Yasue H. Association of remnant lipoproteins levels with impairment of endothelium-dependent vasomotor functions in human coronary arteries. Circulation. 1998;97:2519-2526.
3. Campos E, Nakajima K, Tanaka A, Havel RJ. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoprotein isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 1992;33:369-380.
4. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apoB-100 and anti apoA-1 immunoaffinity mixed gels. Clin Chim Acta. 1993;223:53-71.
5. Nakajima K, Okazaki M, Tanaka A, Pullinger CR, Wang T, Nakano T, Adachi M, Havel RJ. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-1. J Clin Assoc. 1996;19:177-183.
6. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation. 1997;96:3264-3265.
7. Ting HH, Timimi FK, Haley EA, Roddy M-A, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95:2617-2622.
8. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA. 1997;278:1682-1686.
9. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium arterial relaxation by lysolecitin in modified low-density lipoproteins. Nature. 1990;344:160-162.
10. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
11. Spayd RW, Bruschi B, Burdick BA, Dappen GM, Eikenberry JN, Esders TW, Figueras J, Goodhue CT, LaRossa DD, Nelson RW, Rand RN, Wu TW. Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem. 1978;24:1343-1350.
12. Abe K, Yuguchi Y, Katsui G. Quantitative determination of tocopherols by high-speed liquid chromatography. J Nutr Sci Vitaminol (Tokyo). 1975;21:183-188.
13. Yamamoto Y, Brodsky MH, Baker JC, Ames BN. Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography. Anal Biochem. 1987;160:7-13.
14. Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, Mcintyre TM. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Biol Chem. 1989;264:5331-5334.
15. Puhl H, Waeg G, Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 1994;233:425-441.
16. Yamamoto Y, Niki E. Presence of cholesteryl ester hydroperoxide in human blood plasma. Biochem Biophys Res Commun. 1989;165: 988-993.
17. Chiu D, Kuypers F, Lubin B. Lipid peroxidation in human red cells. Semin Hematol. 1989;26:257-276.
18. Brecher G, Bessis M. Present status of spiculed red cells and their relationship to the discocyte-echinocyte transformation: a critical review. Blood. 1972;40:333-344.
19. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-390.
20. Frei B. Reactive oxygen species and antioxidant vitamins: mechanism of action. Am J Med. 1994:97:5S-13S.
21. De Vries N, De Flora S. N-Acetyl-L-cysteine. J Cell Biochem. 1993;17F: 270-277.
22. Bhunia AK, Han H, Snowden A, Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem. 1997;272:15642-15649.
23. Hennig B, Toborek M, Joshi-Barve S, Barger SW, Barve S, Mattson MP, McClain CJ. Linoleic acid activates nuclear transcription factor-κB (NF-κB) and induces NF-κB-dependent transcription in cultured endothelial cells. Am J Clin Nutr. 1996;63:322-328.
24. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Ohta Y, Yasue H. Effects of sphingomyelinase and sphingosine on artenal vasomotor regulation. J Lipid Res. 1996;37:1601-1608.
25. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
26. Kamido H, Kuksis A, Marai L, Myher JJ. Identification of cholesterol-bound aldehydes in copper-oxidized low density lipoprotein. FEBS Lett. 1992;304:269-272.
27. Heery JM, Kozak M, Stafforini D, Jones DA, Zimmerman GA, Mcintyre TM Prescott SM. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322-2330.
28. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Foselman AM, Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272:13597-13607.
29. Esterbauer H, Jurgens G, Quehenberger O, Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 1987;28: 495-509
30. Keaney JF Jr, Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA. Vascular incorporation of α-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest. 1996;98:386-394.
31. Galle J, Busse MR, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb. 1991;11:198-203.
32. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.